Role of thiamine status and genetic variability in transketolase and other pentose phosphate cycle enzymes in the progression of diabetic nephropathy

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1229-1236

  Pcal, Lukáš ^a   Tomandl, Josef ^a   Svojanovský, Jan ^b   Krusová, Darja ^b   Štěpánková, Soňa ^c   Řehořová, Jitka ^c   Olšovský, Jindřich ^b   Bělobrǎdkovǎ, Jana ^c   Tanhäuserová, Veronika ^a   Tomandlová, Marie ^a   Mužík, Jan ^a   Kaňkov, Kateřina ^a  

^a MASARYK UNIVERSITY   (Czech Republic)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c UNIVERSITY HOSPITAL BRNO   (Czech Republic)

Author keywords

diabetic nephropathy; pentose phosphate pathway; thiamine; thiamine deficiency; transketolase

Indexed keywords

CREATININE; DNA FORMAMIDOPYRIMIDINE GLYCOSYLASE; GLUCOSE; HEMOGLOBIN A1C; PENTOSE PHOSPHATE; THIAMINE; TRANSALDOLASE; TRANSKETOLASE; UREA;

ADULT; ARTICLE; BODY MASS; CATALYSIS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE DURATION; ENZYME ACTIVITY; ENZYME MECHANISM; FEMALE; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY DISEASE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MICROALBUMINURIA; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEINURIA; SINGLE NUCLEOTIDE POLYMORPHISM; THIAMINE DEFICIENCY;

ADULT; AGED; CROSS-SECTIONAL STUDIES; DIABETIC NEPHROPATHIES; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; GENOTYPE; GLUCOSE; HUMANS; MALE; MIDDLE AGED; PENTOSE PHOSPHATE PATHWAY; PENTOSEPHOSPHATES; POLYMORPHISM, SINGLE NUCLEOTIDE; SURVIVAL RATE; THIAMINE; TRANSALDOLASE; TRANSKETOLASE;

EID: 79953892222     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq550     Document Type: Article

References (15)

1. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes 2005; 54: 1615-1625 (Pubitemid 40770750)
2. Thornalley PJ. The potential role of thiamine (vitamin B1) in diabetic complications. Curr Diabetes Rev 2005; 1: 287-298
3. Coy JF, Dubel S, Kioschis Pet al. Molecular cloning of tissue-specific transcripts of a transketolase-related gene: implications for the evolution of new vertebrate genes. Genomics 1996; 32: 309-316
4. Coy JF, Dressler D, Wilde J et al. Mutations in the transketolase-like gene TKTL1: clinical implications for neurodegenerative diseases, diabetes and cancer. Clin Lab 2005; 51: 257-273 (Pubitemid 40895125)
5. Thornalley PJ, Babaei-Jadidi R, Al Ali H et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia 2007; 50: 2164-2170 (Pubitemid 47373853)
6. Rabbani N, Alam SS, Riaz S et al. High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia 2009; 52: 208-212
7. Losa R, Sierra MI, Fernandez A et al. Determination of thiamine and its phosphorylated forms in human plasma, erythrocytes and urine by HPLC and fluorescence detection: a preliminary study on cancer patients. J Pharm Biomed Anal 2005; 37: 1025-1029 (Pubitemid 40614833)
8. Brunnekreeft JW, Eidhof H, Gerrits J. Optimized determination of thiochrome derivatives of thiamine and thiamine phosphates in whole blood by reversed-phase liquid chromatography with precolumn derivatization. J Chromatogr 1989; 491: 89-96 (Pubitemid 19181284)
9. Bayoumi RA, Rosalki SB. Evaluation of methods of coenzyme activation of erythrocyte enzymes for detection of deficiency of vitamins B1, B2, and B6. Clin Chem 1976; 22: 327-335
10. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989 (Pubitemid 32289743)
11. Berrone E, Beltramo E, Solimine C et al. Regulation of intracellular glucose and polyol pathway by thiamine and benfotiamine in vascular cells cultured in high glucose. J Biol Chem 2006; 281: 9307-9313 (Pubitemid 43864646)
12. Hammes HP, Du X, Edelstein D et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med 2003; 9: 294-299 (Pubitemid 36362784)
13. Babaei-Jadidi R, Karachalias N, Ahmed N et al. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 2003; 52: 2110-2120 (Pubitemid 36919806)
14. Stracke H, Gaus W, Achenbach U et al. Benfotiamine in diabetic polyneuropathy (BENDIP): results of a randomised, double blind, placebo-controlled clinical study. Exp Clin Endocrinol Diabetes 2008; 116: 600-605
15. Du X, Edelstein D, Brownlee M. Oral benfotiamine plus alpha-lipoic acid normalises complication-causing pathways in type 1 diabetes. Diabetologia 2008; 51: 1930-1932